Prenatal buprenorphine exposure: Effects on biochemical markers of hypoxia and early neonatal outcome [PDF]
Hanna Kahila +5 more
openalex +1 more source
Tina, Hu, Larry, Nijmeh, Adam, Pyle
openaire +2 more sources
Qualitative Analysis of Patient Perspectives of Buprenorphine After Transitioning From Long-Term, Full-Agonist Opioid Therapy Among Veterans With Chronic Pain [PDF]
Sara N. Edmond +6 more
openalex +1 more source
Lynn R Webster,1 Michael Camilleri,2 Andrew Finn3 1PRA Health Sciences, Salt Lake City, UT, 2Mayo Clinic Rochester, MN, 3BioDelivery Sciences, Inc., Raleigh, NC, USA Abstract: Buprenorphine and buprenorphine–naloxone fixed combinations are ...
Webster LR, Camilleri M, Finn A
doaj
Pregnancy Alters CYP- and UGT-Mediated Metabolism of Buprenorphine
Hongfei Zhang +7 more
openalex +2 more sources
Background Improving access to and retention in evidence-based treatment for opioid use disorder, including buprenorphine, is a critical response to the opioid overdose crisis.
Elodie C. Warren +4 more
doaj +1 more source
Anaphylaxis After the Injection of Buprenorphine [PDF]
Cassie L. Boggs +7 more
openalex +1 more source
Donepezil reverses buprenorphine-induced central respiratory depression in anesthetized rabbits
Buprenorphine is a mixed opioid receptor agonist-antagonist used in acute and chronic pain management. Although this agent's analgesic effect increases in a dose-dependent manner, buprenorphine-induced respiratory depression shows a marked ceiling effect
SHIGEKI SAKURABA +5 more
doaj
Human medicines European public assessment report (EPAR): Suboxone, buprenorphine / naloxone, Opioid-Related Disorders, Date of authorisation: 26/09/2006, Revision: 15, Status: Authorised [PDF]
Kernel Networks Inc.
openalex +1 more source
Association between buprenorphine dose and outcomes among pregnant persons with opioid use disorder [PDF]
Marian Jarlenski +6 more
openalex +1 more source

